| 书目名称 | Viral Drug Delivery Systems | | 副标题 | Advances in Treatmen | | 编辑 | Ranjita Shegokar,Yashwant Pathak | | 视频video | | | 概述 | Covers drug delivery for treatment of COVID-19, HIV, SARS, EBOLA and Influenza.Includes information on the latest clinical trials.Presents new nanoparticle delivery systems | | 图书封面 |  | | 描述 | The disability-adjusted life year (DALY) is a generic measure of health effect that can be used in cost-effectiveness analysis as an alternative to the quality-adjusted life year (QALY). Infectious diseases are one of the major to cause significant losses of DALY and QALY. Human infectious diseases are disorders that are triggered by the micro-organisms such as bacteria, fungi, viruses, or parasites. The majority of such diseases are contagious and create a public health menace. There are several reasons why infectious diseases are deadly diseases, and one of the primary reasons is the drug resistance developed over time. Drug resistance-associated mutations are linked to increasing drug efflux, modifications of the drugs, or their targets. Every year, new drugs are being approved by FDA to treat infectious diseases. Nonetheless, the infectious diseases will undoubtedly persist as permanent and main threats to humanity for now and in the future, primarily due to increased longevity that almost always comes at a cost of impaired immunity..A total of four books are covered under the series of Infectious drug diseases..- Malarial drug delivery systems.- Tubercular drug delivery system | | 出版日期 | Book 2023 | | 关键词 | SARS; Ebola; Coronavirus; HIV; infectious disease treatments | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-031-20537-8 | | isbn_softcover | 978-3-031-20539-2 | | isbn_ebook | 978-3-031-20537-8 | | copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl |
The information of publication is updating
|
|
发表于 2025-3-21 17:29:19
